img

Global Sulfonamides Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Sulfonamides Market Research Report 2024

Sulfonamides (sulphonamides) is a man-made group of medicines that includes the sulfonamide chemical group. Which is also called sulfa drugs. Sulfonamide antimicrobials are bacteriostatic (helps to stop generating new bacteria, but don’t surely kill them) and also work by intervening with the fusion of folic acid in bacteria, which is important for the formation of nucleic acid and ultimately for DNA and RNA. Sulfonamides are generally used in the pharmaceutical industry at a high rate. Where it is used as bacteriostatic agents which helps to kill the bacteria from human as well as from the animal’s body. Sulfonamides can be prepared in many ways in the laboratory. Sulfonamides are generally used for diabetes, fluid retention, high blood pressure, crohn’s disease, etc.
According to MRAResearch’s new survey, global Sulfonamides market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sulfonamides market research.
Key companies engaged in the Sulfonamides industry include Pfizer, Sanofi, Roche, Mylan, Teva, Bayer, Abbott, GlaxoSmithKline and Boehringer Ingelheim, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Sulfonamides were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Sulfonamides market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Sulfonamides market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Pfizer
Sanofi
Roche
Mylan
Teva
Bayer
Abbott
GlaxoSmithKline
Boehringer Ingelheim
Segment by Type
Intestinal Absorption
Intestinal Tract Difficult to Absorb
External Use

Segment by Application


Systemic Infection
Intestinal Infection
Burn Infection
Other Infections
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Sulfonamides report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sulfonamides Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Intestinal Absorption
1.2.3 Intestinal Tract Difficult to Absorb
1.2.4 External Use
1.3 Market by Application
1.3.1 Global Sulfonamides Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Systemic Infection
1.3.3 Intestinal Infection
1.3.4 Burn Infection
1.3.5 Other Infections
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sulfonamides Market Perspective (2018-2033)
2.2 Sulfonamides Growth Trends by Region
2.2.1 Global Sulfonamides Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Sulfonamides Historic Market Size by Region (2018-2023)
2.2.3 Sulfonamides Forecasted Market Size by Region (2024-2033)
2.3 Sulfonamides Market Dynamics
2.3.1 Sulfonamides Industry Trends
2.3.2 Sulfonamides Market Drivers
2.3.3 Sulfonamides Market Challenges
2.3.4 Sulfonamides Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sulfonamides Players by Revenue
3.1.1 Global Top Sulfonamides Players by Revenue (2018-2023)
3.1.2 Global Sulfonamides Revenue Market Share by Players (2018-2023)
3.2 Global Sulfonamides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sulfonamides Revenue
3.4 Global Sulfonamides Market Concentration Ratio
3.4.1 Global Sulfonamides Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sulfonamides Revenue in 2022
3.5 Sulfonamides Key Players Head office and Area Served
3.6 Key Players Sulfonamides Product Solution and Service
3.7 Date of Enter into Sulfonamides Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sulfonamides Breakdown Data by Type
4.1 Global Sulfonamides Historic Market Size by Type (2018-2023)
4.2 Global Sulfonamides Forecasted Market Size by Type (2024-2033)
5 Sulfonamides Breakdown Data by Application
5.1 Global Sulfonamides Historic Market Size by Application (2018-2023)
5.2 Global Sulfonamides Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Sulfonamides Market Size (2018-2033)
6.2 North America Sulfonamides Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Sulfonamides Market Size by Country (2018-2023)
6.4 North America Sulfonamides Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sulfonamides Market Size (2018-2033)
7.2 Europe Sulfonamides Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Sulfonamides Market Size by Country (2018-2023)
7.4 Europe Sulfonamides Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sulfonamides Market Size (2018-2033)
8.2 Asia-Pacific Sulfonamides Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Sulfonamides Market Size by Region (2018-2023)
8.4 Asia-Pacific Sulfonamides Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sulfonamides Market Size (2018-2033)
9.2 Latin America Sulfonamides Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Sulfonamides Market Size by Country (2018-2023)
9.4 Latin America Sulfonamides Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sulfonamides Market Size (2018-2033)
10.2 Middle East & Africa Sulfonamides Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Sulfonamides Market Size by Country (2018-2023)
10.4 Middle East & Africa Sulfonamides Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Sulfonamides Introduction
11.1.4 Pfizer Revenue in Sulfonamides Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Sulfonamides Introduction
11.2.4 Sanofi Revenue in Sulfonamides Business (2018-2023)
11.2.5 Sanofi Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Sulfonamides Introduction
11.3.4 Roche Revenue in Sulfonamides Business (2018-2023)
11.3.5 Roche Recent Development
11.4 Mylan
11.4.1 Mylan Company Detail
11.4.2 Mylan Business Overview
11.4.3 Mylan Sulfonamides Introduction
11.4.4 Mylan Revenue in Sulfonamides Business (2018-2023)
11.4.5 Mylan Recent Development
11.5 Teva
11.5.1 Teva Company Detail
11.5.2 Teva Business Overview
11.5.3 Teva Sulfonamides Introduction
11.5.4 Teva Revenue in Sulfonamides Business (2018-2023)
11.5.5 Teva Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Sulfonamides Introduction
11.6.4 Bayer Revenue in Sulfonamides Business (2018-2023)
11.6.5 Bayer Recent Development
11.7 Abbott
11.7.1 Abbott Company Detail
11.7.2 Abbott Business Overview
11.7.3 Abbott Sulfonamides Introduction
11.7.4 Abbott Revenue in Sulfonamides Business (2018-2023)
11.7.5 Abbott Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Detail
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Sulfonamides Introduction
11.8.4 GlaxoSmithKline Revenue in Sulfonamides Business (2018-2023)
11.8.5 GlaxoSmithKline Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Detail
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Sulfonamides Introduction
11.9.4 Boehringer Ingelheim Revenue in Sulfonamides Business (2018-2023)
11.9.5 Boehringer Ingelheim Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Sulfonamides Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Intestinal Absorption
Table 3. Key Players of Intestinal Tract Difficult to Absorb
Table 4. Key Players of External Use
Table 5. Global Sulfonamides Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Sulfonamides Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Sulfonamides Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Sulfonamides Market Share by Region (2018-2023)
Table 9. Global Sulfonamides Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Sulfonamides Market Share by Region (2024-2033)
Table 11. Sulfonamides Market Trends
Table 12. Sulfonamides Market Drivers
Table 13. Sulfonamides Market Challenges
Table 14. Sulfonamides Market Restraints
Table 15. Global Sulfonamides Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Sulfonamides Market Share by Players (2018-2023)
Table 17. Global Top Sulfonamides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sulfonamides as of 2022)
Table 18. Ranking of Global Top Sulfonamides Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Sulfonamides Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Sulfonamides Product Solution and Service
Table 22. Date of Enter into Sulfonamides Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sulfonamides Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Sulfonamides Revenue Market Share by Type (2018-2023)
Table 26. Global Sulfonamides Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Sulfonamides Revenue Market Share by Type (2024-2033)
Table 28. Global Sulfonamides Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Sulfonamides Revenue Market Share by Application (2018-2023)
Table 30. Global Sulfonamides Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Sulfonamides Revenue Market Share by Application (2024-2033)
Table 32. North America Sulfonamides Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Sulfonamides Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Sulfonamides Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Sulfonamides Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Sulfonamides Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Sulfonamides Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Sulfonamides Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Sulfonamides Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Sulfonamides Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Sulfonamides Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Sulfonamides Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Sulfonamides Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Sulfonamides Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Sulfonamides Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Sulfonamides Market Size by Country (2024-2033) & (US$ Million)
Table 47. Pfizer Company Detail
Table 48. Pfizer Business Overview
Table 49. Pfizer Sulfonamides Product
Table 50. Pfizer Revenue in Sulfonamides Business (2018-2023) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. Sanofi Company Detail
Table 53. Sanofi Business Overview
Table 54. Sanofi Sulfonamides Product
Table 55. Sanofi Revenue in Sulfonamides Business (2018-2023) & (US$ Million)
Table 56. Sanofi Recent Development
Table 57. Roche Company Detail
Table 58. Roche Business Overview
Table 59. Roche Sulfonamides Product
Table 60. Roche Revenue in Sulfonamides Business (2018-2023) & (US$ Million)
Table 61. Roche Recent Development
Table 62. Mylan Company Detail
Table 63. Mylan Business Overview
Table 64. Mylan Sulfonamides Product
Table 65. Mylan Revenue in Sulfonamides Business (2018-2023) & (US$ Million)
Table 66. Mylan Recent Development
Table 67. Teva Company Detail
Table 68. Teva Business Overview
Table 69. Teva Sulfonamides Product
Table 70. Teva Revenue in Sulfonamides Business (2018-2023) & (US$ Million)
Table 71. Teva Recent Development
Table 72. Bayer Company Detail
Table 73. Bayer Business Overview
Table 74. Bayer Sulfonamides Product
Table 75. Bayer Revenue in Sulfonamides Business (2018-2023) & (US$ Million)
Table 76. Bayer Recent Development
Table 77. Abbott Company Detail
Table 78. Abbott Business Overview
Table 79. Abbott Sulfonamides Product
Table 80. Abbott Revenue in Sulfonamides Business (2018-2023) & (US$ Million)
Table 81. Abbott Recent Development
Table 82. GlaxoSmithKline Company Detail
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Sulfonamides Product
Table 85. GlaxoSmithKline Revenue in Sulfonamides Business (2018-2023) & (US$ Million)
Table 86. GlaxoSmithKline Recent Development
Table 87. Boehringer Ingelheim Company Detail
Table 88. Boehringer Ingelheim Business Overview
Table 89. Boehringer Ingelheim Sulfonamides Product
Table 90. Boehringer Ingelheim Revenue in Sulfonamides Business (2018-2023) & (US$ Million)
Table 91. Boehringer Ingelheim Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sulfonamides Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Sulfonamides Market Share by Type: 2022 VS 2033
Figure 3. Intestinal Absorption Features
Figure 4. Intestinal Tract Difficult to Absorb Features
Figure 5. External Use Features
Figure 6. Global Sulfonamides Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Sulfonamides Market Share by Application: 2022 VS 2033
Figure 8. Systemic Infection Case Studies
Figure 9. Intestinal Infection Case Studies
Figure 10. Burn Infection Case Studies
Figure 11. Other Infections Case Studies
Figure 12. Sulfonamides Report Years Considered
Figure 13. Global Sulfonamides Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Sulfonamides Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Sulfonamides Market Share by Region: 2022 VS 2033
Figure 16. Global Sulfonamides Market Share by Players in 2022
Figure 17. Global Top Sulfonamides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sulfonamides as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Sulfonamides Revenue in 2022
Figure 19. North America Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Sulfonamides Market Share by Country (2018-2033)
Figure 21. United States Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Sulfonamides Market Share by Country (2018-2033)
Figure 25. Germany Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Sulfonamides Market Share by Region (2018-2033)
Figure 33. China Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Sulfonamides Market Share by Country (2018-2033)
Figure 41. Mexico Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Sulfonamides Market Share by Country (2018-2033)
Figure 45. Turkey Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Sulfonamides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in Sulfonamides Business (2018-2023)
Figure 48. Sanofi Revenue Growth Rate in Sulfonamides Business (2018-2023)
Figure 49. Roche Revenue Growth Rate in Sulfonamides Business (2018-2023)
Figure 50. Mylan Revenue Growth Rate in Sulfonamides Business (2018-2023)
Figure 51. Teva Revenue Growth Rate in Sulfonamides Business (2018-2023)
Figure 52. Bayer Revenue Growth Rate in Sulfonamides Business (2018-2023)
Figure 53. Abbott Revenue Growth Rate in Sulfonamides Business (2018-2023)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Sulfonamides Business (2018-2023)
Figure 55. Boehringer Ingelheim Revenue Growth Rate in Sulfonamides Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries